🔗 Share this article

An underground economy for unapproved weight-loss medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users administering products of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The company said it was committed to keeping the service secure and investing in strengthening compliance measures.

Online Marketplace Operations

Research also found communities with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

Within moments of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Details and Costs

Within these communities, messages display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service stated it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these online products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially significant health risks”.